GUSHENGTANG plans to fully acquire Dazhongtang to expand its market share in Singapore
GUSHENGTANG (02273.HK) announced that its subsidiary Gushengtang Singapore has entered into an equity transfer agreement to acquire 100% equity of Dazhongtang, which mainly engages in providing traditional Chinese medicine services and retail of pharmaceuticals in Singapore. The price will be determined after negotiation between both parties. If the acquisition is successfully completed, the group will add 14 traditional Chinese medicine clinics to its operations
Source: AASTOCKS The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments